Medicina interna
Servicio
University of the Witwatersrand
Johannesburgo, SudáfricaPublicaciones en colaboración con investigadores/as de University of the Witwatersrand (4)
2019
-
An international perspective on hospitalized patients with viral community-acquired pneumonia
European Journal of Internal Medicine, Vol. 60, pp. 54-70
-
Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen
AIDS, Vol. 33, Núm. 10, pp. 1583-1593
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
-
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
The Lancet HIV, Vol. 4, Núm. 11, pp. e486-e494